Home > Company
CORE VALUE
Realize prompt and accurate molecular diagnostics and support early-stage
diagnosis and timely personalized medicine.
We are developing nucleic acid preparation and MDx and CDx technology targeting various infectious diseases and genetic disorders including COVID-19, mycobacterium tuberculosis,
fungal diseases, Orientia tsutsugamushi and liquid biopsy from cancers.
![]() Focus on developing products that exhibit optimal performance in the MDx market. | ![]() Pursue efficient cooperation in a horizontal company culture and releasing a wide range of MDx products. | ![]() Encourage creative thinking and put our efforts on developing innovative products. |
We are focused on developing innovative technology that could continuously contribute to medical diagnosis even in the circumstances of rapidly changing IVD market.
Our development goal is to realize prompt and accurate MDx even when there are low quantity of pathogens from various diseases.
INFUSIONTECH, Inc.ㅣ CEO : Nam Heon, Kim
Tel: +82-31-687-3459
FAX : +82-31-624-1518
E-Mail: infusion@infusiontech.co.kr
#1202, 38, Heungan-daero 427 beon-gil, Dongan-gu, Anyang-si, Gyeonggi-do, Korea
INFUSIONTECH, Inc.ㅣ CEO : Nam Heon, Kim
Tel: +82-31-687-3459 ㅣFAX : +82-31-624-1518 ㅣ E-Mail: infusion@infusiontech.co.kr
#1202, 38, Heungan-daero 427 beon-gil, Dongan-gu, Anyang-si, Gyeonggi-do, Korea
COPYRIGHT INFUSIONTECH © 2020. ALL RIGHTS RESERVED.